The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effect of SSRI Antidepressants on Ejaculation: A Double-Blind, Randomized, Placebo-Controlled Study With Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
Abstract
Depression is a common cause of sexual dysfunction, but also antidepressant medication is often associated with sexual side effects. This article includes two related studies. The first double-blind, placebo-controlled study was conducted in men with lifelong rapid ejaculation and aimed to assess putative differences between the major selective serotonin reuptake inhibitors (SSRIs) (fluoxetine, fluvoxamine, paroxetine, and sertraline) with regard to their ejaculation-delaying effect. Sixty men with an intravaginal ejaculation latency time (IELT) of 1 minute or less were randomly assigned to receive fluoxetine 20 mg/day, fluvoxamine 100 mg/day, paroxetine 20 mg/day, sertraline 50 mg/day, or placebo for 6 weeks. During the 1-month baseline and 6-week treatment periods, the men measured their IELT at home using a stopwatch. The trial was completed by 51 men. During the 6-week treatment period, the geometric mean IELT in the placebo group was constant at approximately 20 seconds. Analysis of variance revealed a between-groups difference in the evolution of IELT delay (p = 0.0004); in the paroxetine, fluoxetine, and sertraline groups there was a gradual increase to about 110 seconds, whereas in the fluvoxamine group, IELT was increased to only approximately 40 seconds. The paroxetine, fluoxetine, and sertraline groups differed significantly (p < 0.001, p < 0.001, p = 0.017, respectively) from placebo but the fluvoxamine group did not (p = 0.38). Compared with baseline, paroxetine exerted the strongest delay in ejaculation, followed by fluoxetine and sertraline. There was no clinically relevant delay in ejaculation with fluvoxamine. In men with lifelong rapid ejaculation, paroxetine delayed ejaculation most strongly, whereas fluvoxamine delayed ejaculation the least. The second double-blind, placebo-controlled study was carried out in men with lifelong rapid ejaculation (IELT < or = 1 minute) and in men with lifelong less-rapid ejaculation (IELT > 1 minute) to investigate whether data about SSRI-induced delayed ejaculation in men with rapid ejaculation may be extrapolated to men with less-rapid ejaculation. After measurement of IELT at home (using a stopwatch) during a 1-month baseline assessment, 32 men with an IELT of 1 minute or less (group 1) or more than 1 minute (group 2) were randomly assigned to receive paroxetine 20 mg/day or placebo for 6 weeks in a double-blind manner. Patients continued to measure their IELTs at home during the 6 weeks of the study. At baseline, 24 patients consistently had IELTs of one minute or less (group 1), and eight patients had IELTs of more than 1 minute (group 2). The geometric mean IELT was 14 seconds in group 1 and 83 seconds in group 2. Twelve patients in group 1 and five in group 2 were randomized to the paroxetine 20 mg/day. The percentage increase in the geometric mean IELT compared with baseline in patients treated with paroxetine was 420% (95% confidence interval [CI], 216-758%) in group 1 and 480% (95% CI, 177-1,118%) in group 2 (p = 0.81). After 6 weeks of treatment with paroxetine, the geometric mean IELT was 92 seconds in group 1 and 602 seconds in group 2 (p < 0.001). Therefore, the paroxetine-induced percentage increase in IELT seems to be independent of the baseline IELT. This suggests that ejaculation-delaying side effects of some SSRIs investigated in men with lifelong rapid ejaculation may be generalized to men with less-rapid ejaculation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waldinger, M. D., Berendsen, H. H. G., Blok, B. F. M., Olivier, B., & Holstege, G. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00183-6 · Cited by 369
Self-citationParoxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1377 · Cited by 369
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior
Ahlenius, S., Larsson, K., Svensson, L., Hjorth, S., Carlsson, A., Lindberg, P., Wikström, H., Sanchez, D., Arvidsson, L.-E., Hacksell, U., et al. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90023-x · Cited by 328
Casper, R. C. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790340082012 · Cited by 279
The identification of a brainstem site controlling spinal sexual reflexes in male rats
Marson, L., & McKenna, K. E. (1990) · Brain Research · doi:10.1016/0006-8993(90)90611-e · Cited by 224
Fluoxetine: clinical pharmacology and physiologic disposition.
Lemberger, L., Bergstrom, R. F., Wolen, R. L., Farid, N. A., Enas, G. G., & Aronoff, G. R. (1985) · PubMed · Cited by 196
Sexual dysfunctions in depression
Mathew, R. J., & Weinman, M. L. (1982) · Archives of Sexual Behavior · doi:10.1007/bf01541593 · Cited by 193
Kara, H., Aydin, S., Agargun, M. Y., Odabas, O., & Yilmaz, Y. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65467-3 · Cited by 187
Fabre, L. F., Abuzzahab, F. S., Amin, M., Claghorn, J. L., Mendels, J., Petrie, W. M., Dubé, S., & Small, J. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00178-8 · Cited by 184
Familial occurrence of primary premature ejaculation
Waldinger, M. D., Rietschel, M., Nöthen, M. M., Hengeveld, M. W., & Olivier, B. (1998) · Psychiatric Genetics · doi:10.1097/00041444-199800810-00007 · Cited by 167
Self-citation
Cited by
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation
Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., Vardi, Y., & Wespes, E. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.020 · Cited by 1,223
Salonia, A., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.06.007 · Cited by 828
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
Disorders of Orgasm and Ejaculation in Men
Rowland, D., McMahon, C. G., Abdo, C., Chen, J., Jannini, E., Waldinger, M. D., & Ahn, T. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01782.x · Cited by 508
Self-citation
Metadata
- Authors
- Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H., & Olivier, B.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1998-08
- Volume
- 18
- Issue
- 4
- Pages
- 274-281
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2070486940
- Cited by
- 380
- References
- 21
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of SSRI Antidepressants on Ejaculation: A Double-Blind, Randomized, Placebo-Controlled Study With Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. https://app.cochat.ai/papers/10.1097/00004714-199808000-00004
- The paper
- Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H., & Olivier, B. (1998). Effect of SSRI Antidepressants on Ejaculation: A Double-Blind, Randomized, Placebo-Controlled Study With Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199808000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.